Cymabay Cash Flow - Quarterly (NASDAQ:CBAY)

Add to My Stocks
$13.74 $1.25 (10.01%) CBAY stock closing price Mar 16, 2018 (Closing)

The Cymabay cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about Cymabay profits and Cymabay debt. Cymabay saw a cash impact of $101.02M from the issuance of CBAY shares. The cash flow statement helps in the Cymabay stock analysis by providing more information for evaluating changes in assets, liabilities and equities. CBAY decrease in investments stood at a value of $-72.62M for the latest quarter 2017 Q3.

View and download details of Cymabay cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow-0.02M--------
Net Increase (Decrease) in Assets Liabilities-0.29M-0.38M-0.39M--0.48M----
Cash From (used in) Discontinued Operations---------
Other Adjustments Net9.27M6.54M3.53M2.87M2.1M1.39M--8.4M-8.95M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment----0.04M-0.04M-0.03M---
Acquisition Disposition of Subsidiaires---------
Increase (Decrease) in Investments-72.62M-0.72M-3.22M27.17M17.35M16.95M19.63M-11.08M-17.29M
Other Cash Inflow (Outflow) from Investment Activities---------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares101.02M9.36M9.36M----25.8M25.8M
Issuance (Repayment) of Debt Securities-2.32M-1.53M-0.75M-0.98M-0.24M--4.72M4.72M
Increase (Decrease) in Bank & Other Borrowings---------
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities---------
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash---------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year7.7M11.58M24.4M7.72M8.02M----
Cash & Equivalents at Year End23M9.5M13.67M10.49M6.82M12.41M21.19M7.7M6.69M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Cymabay stock price history and Cymabay stock comparison chart inevitably reflect its cash flow situation.

  • Cymabay had a Net Change in Cash and Cash Equivalents of $12.51M in the latest quarter 2017 Q3. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Cymabay stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Cymabay lost $-13.56M cash from operations. It is important to check this to see where the company is getting its money from.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-72.62M for CBAY stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $98.7M for Cymabay. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For Cymabay Cash Flow

Quarterly Cash Flow Statements For CymaBay Therapeutics Inc Peers

Amphastar Pharma cash flow, Bristol-Myers Squibb cash flow, Esperion Therapeutics cash flow, Pfizer cash flow